Cargando…

Effect of restoration of 25OHD(3 )status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163

Detalles Bibliográficos
Autores principales:	Ingels, CM, Van Cromphaut, SJ, Wouters, PJ, Moller, HJ, Van Herck, E, Jans, I, Bouillon, R, Berghe, G Van den
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934472/ http://dx.doi.org/10.1186/cc8822

Ejemplares similares

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
por: Bach, Ermina, et al.
Publicado: (2019)

Bone turnover in prolonged critical illness: effect of vitamin D
por: Vanhove, P, et al.
Publicado: (2003)

Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals
por: Yadav, Anjana, et al.
Publicado: (2019)

The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids
por: Thomsen, Henrik H, et al.
Publicado: (2013)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT
por: De Vlieger, Greet, et al.
Publicado: (2019)

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
por: Schönbauer, Robert, et al.
Publicado: (2020)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
por: Rittig, Nikolaj, et al.
Publicado: (2017)

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
por: Silva, Ricardo Luís Louzada, et al.
Publicado: (2017)

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
por: Kjærgaard, Anders G., et al.
Publicado: (2014)

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
por: Stuhr, Liva K., et al.
Publicado: (2023)

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors
por: Castley, Alison, et al.
Publicado: (2016)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
por: Dean, Scott N., et al.
Publicado: (2011)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action
por: Scheenstra, Maaike R., et al.
Publicado: (2019)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
por: Qian, Shushu, et al.
Publicado: (2020)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
por: Marocco, Raffaella, et al.
Publicado: (2022)

Critical illness-induced bone loss is related to deficient autophagy and histone hypomethylation
por: Owen, Helen C, et al.
Publicado: (2015)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_32kveib08tou5ktv6vmda15j0m